Back to search

Article

Simultaneously evaluating efficacy and cardiotoxicity of EGFR-TKI AC0010 with a novel multifunctional biosensor

2022-12-09

Abstract excerpt

Non-small lung cancer (NSCLC) is a leading cause of cancer mortality worldwide. Although epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) have dramatically improved life expectancy for NSCLC patients, concerns about TKI-induced cardiotoxicities increased. AC0010, a novel third-generation TKI, was developed to overcome acquired EGFR-T790M mutation-induced drug resistance. However, the cardiot...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2c128d4e-bc52-594b-b423-c6b2dc1e1787
DOI
10.21203/rs.3.rs-2146794/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Simultaneously evaluating efficacy and cardiotoxicity of EGFR-TKI AC0010 with a novel multifunctional biosensorDOI 10.21203/rs.3.rs-2146794/v1
Select a neighboring publication to make it the new centre.